4th Metronomic Chemotherapy Meeting

Dr Banavali talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about drug repurposing to overcome economic difficulties in global cancer care.

Prof Bocci talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the benefits of metronomic treatment. He highlights the difficulties faced in trying to research such treatment in light of limited knowledge on the mechanics and biomarkers which make it work, as well as logistical difficulties, such as funding.

Prof Shaked talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the benefits of a metronomic chemotherapy regimen as a less aggressive treatment than high dose chemotherapy, and a more effective maintenance drug, preventing relapse and decreasing metastatic burden.

Dr Hutchinson talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the work of her journal, Nature Reviews Clinical Oncology, and the benefits of metronomic chemotherapy and drug repurposing, whilst noting the challenges facing it such as a lack of rigorous definitions and terminology, limited knowledge about dosage efficacy, and difficulties surrounding funding.

Dr André talks to ecancertv at the Metronomic Chemotherapy meeting in Milan about the use of metronomic chemotherapy in frail and unfit patients, as well as its benefits as an orally administered treatment. and one that is cost-effective for low-income countries. In particular, he discusses the aims and work of the Metronomic Global Health Initiative. In addition, he notes the strides being made in drug repurposing.

Dr Sterba talks to ecancertv at the Metronomics in Chemotherapy Meeting in Milan about the benefits of metronomic therapy in treating neuroblastoma, including cost-effectiveness. In addition, he discusses the ways in which this approach can be combined with other treatment strategies such as immunotherapy.

Dr Pasquier talks to ecancertv at the Metronoimc Chemotherapy Meeting in Milan about drug repurposing with particular reference to the use of betablockers in paediatric neuroblastoma.

Dr Bouche talks to ecancertv at the Metronomic Chemotherapy Meeting about the 'ReDO' project, which promotes clinical research on repurposing generic drugs to treat cancer.

Prof Berthold talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the use of metronomic therapy in treating children with neuroblastoma.

Dr Bertolini talks to ecancertv at the 4th Metronomic Chemotherapy Meeting in Milan about metronomic therapy and drug repurposing with particular reference to the use of metformin against breast cancer, formerly used in diabetes.

Dr Eniu talks to ecancertv at the Metronomic Chemotherapy Meeting in Milan about the treatment of cancer in low- and middle-income countries, with a particular focus on breast cancer.